MHRA Approves Gene-Editing Treatment for Children Aged 5 and Over
The UK medicines regulator approved the treatment for children aged 5 and over with serious inherited blood disorders.
The UK medicines regulator approved the treatment for children aged 5 and over with serious inherited blood disorders.